Why watch this on-demand webinar
Trying to recover analytes—including proteins, nucleic acids, bacteria or viruses—from dried blood samples?
Struggling with the reproducibility and reliability of existing dried blood microsampling technologies?
In this webinar, experts from Porex and ReadyGo will show how Porex’s engineered porous fiber technology forms the foundation of a reliable dried blood microsampling approach, enabling consistent analyte recovery, ambient stabilization, and simplified workflows that overcome the limitations of conventional dried blood spot methods.
Built using Porex’s engineered porous fiber platform, GoCollect® Dry is a dry-state microsampling device designed to collect, stabilize, and transport biological samples in a test-ready format for downstream analysis. Combined with ReadyGo’s proprietary chemistry, the Porex fiber matrix supports consistent recovery of proteins, nucleic acids, and immune cell-associated biomarkers from dried blood samples, while eliminating many of the handling and cold-chain challenges associated with traditional workflows.
Dr. Ben Cobb, Founder and CEO of ReadyGo, will present data from a multi-donor study conducted with Epimune™ Diagnostics comparing GoCollect® Dry with conventional liquid blood collection. Using qPCR analysis of isolated mRNA, researchers observed comparable relative expression of biomarkers associated with T cells (CD3+, CD4+, CD8+), B cells, and natural killer (NK) cells between dried and liquid samples, suggesting the Porex fiber matrix preserves representative immune cell population profiles for downstream immunogenomic analysis. The study also demonstrated quantitative recovery of genomic DNA proportional to sample input volume, along with minimal measurable loss of plasmid DNA to the Porex fiber matrix.
Dr. Ayo Olanrewaju of the University of Washington will share preliminary findings from an HIV therapeutic monitoring study utilizing GoCollect® Dry, with early results suggesting analytical performance comparable to traditional wet collection while delivering the logistical advantages of dry-state sampling.
Together, these studies demonstrate how Porex fiber materials support reliable molecular analysis while substantially simplifying dried blood collection workflows. Register to learn how Porex’s engineered porous fiber technology can support decentralized diagnostics and molecular testing applications.
Who Should Attend ?
- Product Development and Innovation teams in Diagnostics
- R&D Scientists and Engineers working on sample collection and molecular testing workflows
- Assay Development and Translational Research professionals
- Professionals interested in decentralized diagnostics and dried blood spot workflows
In this webinar, you will learn:
- How these material technologies can recover a wide range of analytes, including small molecules, proteins, bacteria, viruses and immune cells, on par with standard liquid blood samples
- The power of combining innovative material science with unique chemistries to collect, preserve and release dried blood microsamples
Speakers:
Ellen Weinzapfel,
PhD, Global Marketing Manager, Porex
Ellen Weinzapfel, PhD, is the Global Marketing Manager at Porex, where she supports diagnostic and medtech customers developing advanced sample collection and biomolecule isolation solutions. She works closely with R&D, product development and commercial teams to translate material science capabilities into application-specific solutions for noninvasive sampling and decentralized diagnostics.
Ben Cobb,
PhD, Founder and CEO, ReadyGo™ Diagnostics
Ben has spent his entire career innovating new diagnostic products and has founded several public and private start-ups. Some of his products have now become embedded into routine clinical practice, including Genedrive® which was arguably the world’s first true point-of-care molecular platform and is providing a new standard of NHS care. As CEO, Ben is responsible for overseeing ReadyGo’s day-to-day operations, the delivery of its strategy and new product innovation.
Ayokunle Olanrewaju,
PhD, Assistant Professor, University of Washington
Dr. Ayokunle Olanrewaju is an Assistant Professor in the Departments of Mechanical Engineering and Bioengineering at the University of Washington, where his research focuses on developing innovative diagnostic and therapeutic monitoring technologies for point-of-care and decentralized healthcare applications. His work combines microfluidics, molecular assays and translational bioengineering to create rapid, user-friendly systems for disease monitoring and therapeutic drug analysis, particularly in HIV treatment and prevention.
Sign up to receive the webinar link and watch on demand